Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Jun 2026 for Cognition Therapeutics INC. Read the official filing
Filing timeline
BuySalePeggy Wallace
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-24.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Peggy Wallace: trading record in brief
Peggy Wallace, listed as board member, appears in our data through filings on Cognition Therapeutics Inc shares, published by SEC (Form 4). The record holds 7 filings, for trades running from 13 October 2021 to 17 June 2026.
Every open-market trade on record is a purchase: 2 purchases worth €46k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 4 share grants.
The newest entry dates from 22 June 2026: a share grant, in Cognition Therapeutics Inc. The last insider purchase was made public on 16 November 2022, 1,435 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Peggy Wallace
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
25,000 sharesCommon StockSEC:0001104659-26-076472:0
34,000 shares0Common StockSEC:0001062993-25-012081:0
8,500 shares0Common StockSEC:0001062993-24-012414:0
6,000 shares0Common StockSEC:0001062993-23-013440:0
12,500 shares@ US$1.2019.0% of flowCommon StockSEC:0001062993-22-022242:0
Canonical exit: 13 Feb 2023 (T+90)
22,461 shares0Common StockSEC:0001062993-22-020049:0
3,000 shares@ US$12.0068.1% of flowCommon StockSEC:0001882178-21-000036:0
Canonical exit: 11 Jan 2022 (T+90)
7 of 7 declarations
